Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Increased serum concentrations of transforming growth factor-β1 (TGF-β1) in patients with Guillain-Barré syndrome.
Neurogenic bowel dysfunction (NBD) translation and linguistic validation to classical Arabic.
The choroid plexus in health and in disease: Dialogues into and out of the brain.
Upregulation of CD4+T-Cell Derived MiR-223 in The Relapsing Phase of Multiple Sclerosis Patients.
Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarate.
Encephalomyelitis Associated With Dengue Fever.
Comparative evaluation of patients' and physicians' satisfaction with interferon beta-1b therapy.
Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis.
Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand.
Three cases of neuromyelitis optica spectrum disorder.
Relationship between Visual Dysfunction and Retinal Changes in Patients with Multiple Sclerosis.
Successful surgical treatment of scoliosis secondary to Guillain-Barré syndrome: Case report.
Perspectives on Safety and Efficacy-The BOLD Phase 2 Extension Study of Siponimod in Relapsing-Remitting Multiple Sclerosis.
Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing-Remitting Multiple Sclerosis.
MRI Patterns of Isolated Lesions in the Medulla Oblongata.
Effect of Fingolimod-Treatment on Blood Lipid Profiles of Multiple Sclerosis Patients.
Mast cells: New therapeutic target in helminth immune modulation.
Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis.
Longitudinal Study of Retinal Nerve Fiber Layer Thickness and Macular Volume in Patients With Neuromyelitis Optica Spectrum Disorder.
Longitudinal changes in sickness absence and disability pension, and associations between disability pension and disease-specific and contextual factors and functioning, in people with multiple sclerosis.
Pseudo-Foster Kennedy Syndrome as a Rare Presentation of Vitamin B12 Deficiency.
Measuring Brain Tissue Integrity during 4 Years Using Diffusion Tensor Imaging.
Tiam1/Rac1 complex controls Il17a transcription and autoimmunity.
The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Pages
« first
‹ previous
…
808
809
810
811
812
813
814
815
816
…
next ›
last »